NEW YORK, Aug. 29 – British DNA sequencer Whatman and Dutch firms PamGene and Plant Research International have entered into a three-way, four-year partnership to develop rapid assays for agrotechnology, the companies announced on Wednesday.
The research, which will be conducted in Plant Research’s labs, will rely on PamGene’s PamChip microarray technology and Whatman’s nucleic acid isolation technology.
The partners hope to develop technology that can detect “plant pathogens or pests that are implicated in the destruction of plants or crops of economic importance,” the companies said in a statement.
It was not immediately clear what those plants or crops are, and representatives from 's-Hertogenbosch-based PamGene or Plant Research, of Wageningen, were not available for comment.
A spokesman for Maidstone-based Whatman said that the research contract between the three groups would cost roughly $700,000 after the four years.